ArticleCancer science2018

Combined inhibition of MEK and PI3K pathways overcomes acquired resistance to EGFR-TKIs in non-small cell lung cancer.

Hiroki Sato et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.